ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $63,000 | +12.5% | 36,500 | -19.8% | 0.00% | 0.0% |
Q2 2022 | $56,000 | +19.1% | 45,500 | -35.9% | 0.00% | 0.0% |
Q1 2022 | $47,000 | -39.0% | 71,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $77,000 | -67.0% | 71,000 | -44.7% | 0.00% | -75.0% |
Q3 2021 | $233,000 | -45.9% | 128,300 | -21.4% | 0.00% | -50.0% |
Q2 2021 | $431,000 | +43.2% | 163,300 | +94.9% | 0.01% | +33.3% |
Q1 2021 | $301,000 | +312.3% | 83,800 | +189.0% | 0.01% | +200.0% |
Q4 2020 | $73,000 | 0.0% | 29,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $73,000 | -24.0% | 29,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $96,000 | +35.2% | 29,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $71,000 | -48.2% | 29,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $137,000 | +9.6% | 29,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $125,000 | -23.3% | 29,000 | +3.6% | 0.00% | -25.0% |
Q2 2019 | $163,000 | +17.3% | 28,000 | -22.2% | 0.00% | 0.0% |
Q1 2019 | $139,000 | +113.8% | 36,000 | +2.9% | 0.00% | +100.0% |
Q4 2018 | $65,000 | +85.7% | 35,000 | +218.2% | 0.00% | +100.0% |
Q3 2018 | $35,000 | +6.1% | 11,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $33,000 | -35.3% | 11,000 | -15.4% | 0.00% | 0.0% |
Q1 2018 | $51,000 | -7.3% | 13,000 | -3.0% | 0.00% | 0.0% |
Q4 2017 | $55,000 | -36.0% | 13,400 | -4.3% | 0.00% | -50.0% |
Q3 2017 | $86,000 | -23.2% | 14,000 | -22.2% | 0.00% | -33.3% |
Q2 2017 | $112,000 | +49.3% | 18,000 | +50.0% | 0.00% | +50.0% |
Q1 2017 | $75,000 | -53.1% | 12,000 | -60.0% | 0.00% | -60.0% |
Q4 2016 | $160,000 | +44.1% | 30,000 | +53.8% | 0.01% | +66.7% |
Q3 2016 | $111,000 | +0.9% | 19,500 | -3.0% | 0.00% | 0.0% |
Q2 2016 | $110,000 | -22.5% | 20,100 | +4.8% | 0.00% | -25.0% |
Q1 2016 | $142,000 | -12.9% | 19,181 | -2.6% | 0.00% | -20.0% |
Q4 2015 | $163,000 | -2.4% | 19,700 | +5.9% | 0.01% | 0.0% |
Q3 2015 | $167,000 | +35.8% | 18,600 | +81.7% | 0.01% | +66.7% |
Q2 2015 | $123,000 | +13.9% | 10,238 | +2.4% | 0.00% | 0.0% |
Q1 2015 | $108,000 | +176.9% | 10,000 | 0.0% | 0.00% | +200.0% |
Q3 2013 | $39,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |